|
1
|
Davis TME, Peters KE, Bruce DG and Davis
WA: Prevalence, incidence, and prognosis of hepatobiliary disease
in community-based patients with type 2 diabetes: The Fremantle
Diabetes Study. J Clin Endocrinol Metab. 97:1581–1588. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB, Tran T and Everhart JE:
Diabetes increases the risk of chronic liver disease and
hepatocellular carcinoma. Gastroenterology. 126:460–468. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garcia-Compean D, Jaquez-Quintana JO,
Gonzalez-Gonzalez JA and Maldonado-Garza H: Liver cirrhosis and
diabetes: Risk factors, pathophysiology, clinical implications and
management. World J Gastroenterol. 15:280–288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perseghin G, Mazzaferro V, Sereni LP,
Regalia E, Benedini S, Bazzigaluppi E, Pulvirenti A, Leão AA,
Calori G, Romito R, et al: Contribution of reduced insulin
sensitivity and secretion to the pathogenesis of hepatogenous
diabetes: Effect of liver transplantation. Hepatology. 31:694–703.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marchetti P: New-onset diabetes after
liver transplantation: From pathogenesis to management. Liver
Transpl. 11:612–620. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carey EJ, Aqel BA, Byrne TJ, Douglas DD,
Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS and Chakkera
HA: Pretransplant fasting glucose predicts new-onset diabetes after
liver transplantation. J. Transplant. 2012:6147812012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dong M, Parsaik AK, Eberhardt NL, Basu A,
Cosio FG and Kudva YC: Cellular and physiological mechanisms of
new-onset diabetes mellitus after solid organ transplantation.
Diabet Med. 29:e1–e12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tominaga M, Makino H, Yoshino G, Kuwa K,
Takei I, Aono Y, Hoshino T, Umemoto M, Shimatsu A, Sanke T, et al:
Japanese standard reference material for JDS Lot 2 haemoglobin A1c.
I: Comparison of Japan Diabetes Society-assigned values to those
obtained by the Japanese and USA domestic standardization
programmes and by the International Federation of Clinical
Chemistry reference laboratories. Ann Clin Biochem. 42:41–46. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mari A, Pacini G, Murphy E, Ludvik B and
Nolan JJ: A model-based method for assessing insulin sensitivity
from the oral glucose tolerance test. Diabetes Care. 24:539–548.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsuda M and DeFronzo RA: Insulin
sensitivity indices obtained from oral glucose tolerance testing:
Comparison with the euglycemic insulin clamp. Diabetes Care.
22:1462–1470. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stumvoll M, Mitrakou A, Pimenta W, Jenssen
T, Yki-Järvinen H, Van Haeften T, Renn W and Gerich J: Use of the
oral glucose tolerance test to assess insulin release and insulin
sensitivity. Diabetes Care. 23:295–301. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stancáková A, Javorský M, Kuulasmaa T,
Haffner SM, Kuusisto J and Laakso M: Changes in insulin sensitivity
and insulin release in relation to glycemia and glucose tolerance
in 6,414 Finnish men. Diabetes. 58:1212–1221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watt KDS, Pedersen RA, Kremers WK,
Heimbach JK and Charlton MR: Evolution of causes and risk factors
for mortality post-liver transplant: Results of the NIDDK long-term
follow-up study. Am J Transplant. 10:1420–1427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshizumi T, Shirabe K, Taketomi A,
Uchiyama H, Harada N, Ijichi H, Yoshimatsu M, Ikegami T, Soejima Y
and Maehara Y: Risk factors that increase mortality after living
donor liver transplantation. Transplantation. 93:93–98. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dare AJ, Plank LD, Phillips ARJ, Gane EJ,
Harrison B, Orr D, Jiang Y and Bartlett AS: Additive effect of
pretransplant obesity, diabetes, and cardiovascular risk factors on
outcomes after liver transplantation. Liver Transpl. 20:281–290.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zein NN, Abdulkarim AS, Wiesner RH, Egan
KS and Persing DH: Prevalence of diabetes mellitus in patients with
end-stage liver cirrhosis due to hepatitis C, alcohol, or
cholestatic disease. J Hepatol. 32:209–217. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yong CM, Sharma M, Ochoa V, Abnousi F,
Roberts J, Bass NM, Niemann CU, Shiboski S, Prasad M, Tavakol M, et
al: Multivessel coronary artery disease predicts mortality, length
of stay, and pressor requirements after liver transplantation.
Liver Transpl. 16:1242–1248. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Siegel AB, Lim EA, Wang S, Brubaker W,
Rodriguez RD, Goyal A, Jacobson JS, Hershman DL, Verna EC, Zaretsky
J, et al: Diabetes, body mass index, and outcomes in hepatocellular
carcinoma patients undergoing liver transplantation.
Transplantation. 94:539–543. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Defronzo RA: Banting Lecture. From the
triumvirate to the ominous octet: A new paradigm for the treatment
of type 2 diabetes mellitus. Diabetes. 58:773–795. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Henchoz E, D'Alessio DA, Gillet M, Halkic
N, Matzinger O, Goy JJ, Chioléro R, Tappy L and Schneiter P:
Impaired insulin response after oral but not intravenous glucose in
heart- and liver-transplant recipients. Transplantation.
76:923–929. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stockmann M, Konrad T, Nolting S,
Hünerbein D, Wernecke KD, Döbling H, Steinmüller T and Neuhaus P:
Major influence of liver function itself but not of
immunosuppression determines glucose tolerance after living-donor
liver transplantation. Liver Transpl. 12:535–543. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Watt KD, Dierkhising R, Fan C, Heimbach
JK, Tillman H, Goldstein D, Thompson A, Krishnan A and Charlton MR:
Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity
after liver transplantation: Insight into mechanisms of disease. Am
J Transplant. 13:2450–2457. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ling Q, Xie H, Lu D, Wei X, Gao F, Zhou L,
Xu X and Zheng S: Association between donor and recipient TCF7L2
gene polymorphisms and the risk of new-onset diabetes mellitus
after liver transplantation in a Han Chinese population. J Hepatol.
58:271–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Johansson LE, Lindblad U, Larsson CA,
Råstam L and Ridderstråle M: Polymorphisms in the adiponutrin gene
are associated with increased insulin secretion and obesity. Eur J
Endocrinol. 159:577–583. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iwata M, Maeda S, Kamura Y, Takano A, Kato
H, Murakami S, Higuchi K, Takahashi A, Fujita H, Hara K, et al:
Genetic risk score constructed using 14 susceptibility alleles for
type 2 diabetes is associated with the early onset of diabetes and
may predict the future requirement of insulin injections among
Japanese individuals. Diabetes Care. 35:1763–1770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ling Q, Dong F, Geng L, Liu Z, Xie H, Xu X
and Zheng S: Impacts of TCF7L2 gene polymorphisms on the
susceptibility of hepatogenous diabetes and hepatocellular
carcinoma in cirrhotic patients. Gene. 522:214–218. 2013.
View Article : Google Scholar : PubMed/NCBI
|
